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ABSTRACT
The interest in adipogenesis stems from the high rate of obesity in the world and
the motivation to better understand the process of cell fate in relation to human diseases.
Mutations in MED12 lead to developmental disorders and certain malignancies. To date,
specific roles of Mediator and MED12 in cell state regulation are unclear, nevertheless,
they are critical for understanding stem cell regulation and enhancement of their clinical
applications. This study investigates the role of MED12 in relation to the Mediator complex
kinase domain to better understand transcriptional control of adipogenesis in hASCs. In
this study, MED12 expression was diminished with MED12 specific siRNA and
adipogenesis was induced/assessed at different time points (day 3,7 and 14) using phase
imaging to detect lipid droplets with Oil red-O staining being used to further validate
differentiation and visualize the cells. To validate and confirm the effects of the MED12
knockdown, qRT-PCR and western blot analysis was carried out. To determine the role of
MED12 as it functions in the Mediator complex and its role in maintaining the structural
integrity of the kinase module, Coimmunoprecipitation assays were carried out. Results
from this study show that in the absence of MED12, there is a significant decrease in the
number of lipid vesicles compared to the negative control as observed via oil red-O staining
and a decrease in the expression of adipogenic transcription factors such as PPARγ and
C/EBPα via qRT-PCR and western blot analysis. Results also indicated that MED12
interacts with the adipogenic transcription factors to direct proper gene expression and
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indicates a role for MED12 and the Mediator complex in directing the process of
transcription during adipogenesis. Taken together, these data suggest a significant role for
MED12 in regulating adipogenesis and will initiate new research into understanding the
regulatory mechanisms of adipogenesis and offer insight into novel treatments for obesity
and relevant human disease.
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CHAPTER 1
INTRODUCTION

1.1

Stem Cells

Stem cells are undifferentiated cells that have self-renewing capabilities and
the potential to differentiate into multiple lineages and cell types. They are found in
multicellular organisms and are part of a repair system that aids in regeneration following
tissue damage1. Stem cells renew themselves through cell division and can be induced to
form organ specific cells. Also, stem cells are employed for the treatment and prevention
of diseases, including the treatment of cancer1.
Stem cells are categorized into two groups: embryonic stem cells (ESCs) and adult
stem cells. ESCs are derived from the inner cell mass of a developing blastocyst and are
pluripotent, giving rise to cells from all three germ layers: ectoderm, mesoderm and
endoderm1,2. Embryonic stem cells have greatly contributed to our understanding of
developmental biology and advancements in medicine. These cells were the primary focus
of stem cell research in the 1990s and early 2000s, but due to the ethical and political
concerns about the source of these cells, efforts have been made to identify and characterize
additional sources of stem cells that are more easily obtained and even more clinically
relevant3.
Adult stem cells (ASCs) are multipotent cells characterized and named after their
tissue of origin: umbilical cord blood, adipose tissue, blood, placenta, etc. Examples of
1
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adult stem cells include hematopoietic stem cells, which are isolated from the bone marrow
and give rise to blood cells and mesenchymal stem cells found in bone marrow, adipose
tissue, and umbilical cord blood or tissue, that gives rise to connective tissues and bones.
Adipose stem cells are under recent intense investigation as they have the potential to
differentiate into, bone, fat, and cartilage (Figure 1-1).

Figure 1-1: Human mesenchymal stem cells are derived from multiple
adult tissues in the body and undergo differentiation into various lineages.
(Figure adapted from Katsuda et al 2013 and generated by Rachel Eddy in
the Newman lab).
Adipose stem cells are the focus of current research because adipose tissue is
relatively abundant in the human body and can be easily collected in large quantities, with
fewer donor site injuries3,4. Subcutaneous adipose tissue is the most clinically applicable
source of ASCs and is retrieved from the abdomen, arm, or thigh of the human body4. Due
to its mesodermal origin, ASCs differentiate into adipogenic, osteogenic, chondrogenic and
neurogenic lineages through a complex cascade of transcriptional and non-transcriptional
pathways. Also, adipose stem cells have the potential to differentiate into various cells of
the endodermal and ectodermal lineages including neuron-like cells, endothelial cells,
pancreatic cells, and hematopoietic cells5.
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1.2

Clinical applications of adipose stem cells

Presently there is great clinical potential for adult stem cells derived from adipose
tissue, blood, and bone marrow, which makes these stem cells potential targets for clinical
research and regenerative medicine. Adult stem cells have immunomodulatory properties
that have influenced their use as an effective option to treat autoimmune and inflammatory
conditions, like multiple sclerosis4. Adult stem cells secrete numerous growth factors and
cytokines which are necessary for wound healing as they contribute to improved
vascularization in wounds, increased macrophage recruitment, and enhanced tissue
granulation in wound healing6. A study by Rigotti et al in 2007 showed that adult stem
cells were useful in the treatment of wounds complicated by ischemia in patients living
with diabetes7. This study led to further findings that adult stem cells may be effective in
the treatment of several other conditions such as atrophy, fibrosis, retractions, and ulcers
induced by radiation therapy7.
Adipose stem cells in regenerative medicine have shown great clinical potential in
bone regeneration and are currently yielding exciting and promising results. For example,
in 2004, Landeckal et al described the first clinical use of adipose stem cells in a 7-year old
girl reported to have calvarial defects after severe head injury with multi-fragment calvarial
fractures8, 9. Stromal vascular fraction (SVF) obtained from adipose tissue was placed at
various locations of the fracture and computed tomography scans showed the formation of
new bone three months after the reconstruction9. From this research it was observed that
adipose stem cells have greater advantages when compared to bone marrow derived
mesenchymal stem cells especially with regards to cell yield for pediatric patients9.
Adipose stem cells are being investigated for their therapeutic effects in particular
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chondrocytes, cardiac wall regeneration, functional repair after myocardial infarction, and
functional improvement after stroke10. Studies have shown that adipose stem cells may be
a better option for clinical trials due to its high yield in the body and the fact that they
require minimal manipulation before delivery11,12.
1.3

Adipogenesis

Adipose tissue is a multifaceted organ that performs several important
physiological functions such as lipid metabolism, whole-body insulin sensitivity and
systemic energy homeostatis13–15. Adipose tissue consists of several cell types including
endothelial cells, fibroblasts, macrophages, pericytes and other immune cells14. The major
function of adipocytes is to store energy in the form of triglycerides to be used during
periods of calorie insufficiency. Adipogenesis follows commitment and is when
undifferentiated precursor cells restrict their fate to the adipogenic lineage, accumulate
nutrients, and differentiate into filled mature fat cells13,15–20 (Figure 1-2).
Several families of transcription factors along with external cues from the environment
drive adipogenesis. PPARγ, C/EBPα C/EBPβ, EGR1, EGR2 and SREBP1c are specific
transcription factors that have been shown to induce early adipogenesis, with PPARγ being
the most critical transcription factor required for adipocyte cell development, early
adipogenesis and lineage commitment21.

5

Figure 1-2: The differentiation of hASCs to lipid filled adipocytes. This
is a 21-day process in the lab that yields visible lipid vesicles that can be
stained using Oil Red O. Illustration credit: Jessica Trinh, VISTA Center.

The process of adipogenesis in vitro is a highly ordered and well-characterized
sequence of events. It starts with a growth arrest of proliferating pre-adipocytes in cultured
cell lines induced by the addition of a pro-differentiation hormone regimen and by an
additional round of clonal expansion (cell division)14. During adipocyte cell differentiation,
PPARγ, the master regulator of adipogenesis, increases in expression and activity in
fibroblasts or myocytes promoted to undergo adipogenesis. Previous studies have
suggested that PPARγ is involved in adipogenesis because it is observed at higher levels
in adipocytes of morbidly obese individuals as compared to individuals with a normal body
weight21. The systematic coordination of signaling pathways and transcription factors
requires critical regulation to properly monitor changes in gene expression. This suggests
that the transcription factors must be activated or repressed in a specified sequence while
inhibiting other lineage fates of adult stem cells that are also set up to undergo
differentiation into myoblasts, chondrocytes, or osteocytes17.
1.4

Transcription and Control of Gene Expression

Transcription is the first step in gene expression. During transcription, information
from a gene is used to initiate construction of a functional product such as a protein or non-
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coding regulatory RNA. Transcription factors are proteins that bind to specific sequences
of the DNA to direct transcription22. Transcription factors rely on coactivators to
communicate with the general transcription machinery, and they ensure that biological
inputs received from signaling cascades are translated into specific gene expression
programs. It is noteworthy to state that transcription factors control the gene expression
programs that establish and maintain the state of the cells23. Three classes of transcription
factors that influence adipocyte cell development have been identified. They include the
PPAR family, C/EBPs and the ADD1/SREBP family.
PPARγ, the master regulator of adipogenesis, is the most specific of the PPAR
family of transcription factors in adipogenesis and is expressed at very high levels in
adipose tissues and adipocyte cell lines24,25. PPARγ is a subgroup of the nuclear hormone
receptor and is implicated in the transcriptional activation of adipocyte differentiation.
PPARγ can induce adipocyte differentiation of preadipocytes, myoblasts and multipotent
stem cells and is necessary to promote adipocyte cell differentiation. PPARγ must
heterodimerize with another nuclear hormone receptor to bind DNA and be
transcriptionally active. Each member of the PPAR family serves different functions in
vivo26. They exhibit unique tissue distribution and have different affinities for different
response elements. PPARγ activates the promoters of many other fat cell specific genes
and can be activated by synthetic compounds such as thiazolidinediones (TZDs) which are
used as anti-diabetic agents24,25.
The C/EBP family consists of six isoforms, all of which belong to a basic leucine
zipper class of transcription factors. C/EBPs undergo transcriptional regulation at many
levels and are measured by mRNA levels present in the cells. cAMP, an inducer of
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adipogenesis, enhances the expression of C/EBPα and C/EBPβ. Both in vitro and in vivo
experiments have established that C/EBPs (α, β, and δ) promote adipocyte differentiation.
Results from in vivo studies carried out in mice observed that C/EBPβ and C/EBPδ
deficient mice showed a phenotype having substantially low lipid accumulation27.
The adipocyte determination and differentiation factor 1 (ADD1/SREBP1c) family
belong to the basic helix-loop-helix family of transcription factors. SREBP1c plays a role
in tissue specific gene regulation of muscles within the same mesodermal origin with fat
cells28–30. Previous studies have shown that SREBP1 family induces preadipocyte cells to
differentiate into mature fat cells and the overexpression resulted in high levels of
adipocyte marker expression and lipid deposit accumulation within the cells29. Previous
studies have shown a relationship between SREBP1 and PPARγ which leads to an increase
in transcriptional activity when they work together as compared to SREBP1 alone. This
may suggest that ADD1/SREBP may be responsible for generating some factors that
enhance the activity of PPARγ25,27,29.

1.5

The Mediator Complex

The human Mediator complex is a large 1 million Dalton macromolecular complex
that is conserved in all eukaryotes from yeast to humans. The Mediator complex consists
of 25-31 subunits, depending on organism, and is arranged in four modules: the head, the
middle, the tail and the kinase module which consists of MED12, MED13, CDK8 and
Cyclin C31 (Figure 1-3). American chemist Roger Kornberg first discovered the Mediator
complex in 1990 and in 2006 won a Nobel Prize in Chemistry for his research on the
molecular basis of eukaryotic transcription. Kornberg’s research was centered on
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transcription and understanding how genetic materials are transferred to different parts of
the body, a process that is vital to an organism’s existence32. The mammalian Mediator
complex exists in two forms and comprises up to 30 proteins. The core Mediator complex
contains 26 subunits and is required as a strong coactivator of transcription while the other
form, referred to as MED12-Mediator, consists of the kinase module and the 26 core
subunits. The MED12-Mediator complex is capable of regulating transcription both
positively and negatively, depending on context. Alterations of specific subunits of the
Mediator complex is usually associated with several developmental disorders and human
diseases such as Lujan syndrome, Opitz-Kaveggia syndrome, schizophrenia, cancer, and
most cardiovascular diseases33–35.

Figure 1-3: Mediator is a 30-subunit complex comprised of four modules that
links the various interactions between enhancer-bound, cell-type specific
transcription factors and transcriptional machinery at gene promoters.
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The observable function of Mediator is to link interactions between the enhancerbound specific transcription factors that regulate the cell fate to the promoter region of the
target genes. Mediator can physically interact with a collection of transcriptional regulatory
proteins, including DNA-binding transcription factors, RNA polymerase II, general
initiation factors, and transcription elongation factors. Also, Mediator has been used as a
factor in the identification of super enhancers. Super enhancers are referred to as elements
of the genome where a significant number of cell type specific transcription factors come
together to direct transcription(Figure 1-4)36–38. Because of these interactions, mutations or
alterations of the Mediator complex can contribute to many types of cancer, as well as
neurological, developmental, and metabolic disorders36.
The head and middle module play an essential role in stabilizing the interaction of
transcription factors and RNAP II during pre-initiation complex (PIC) assembly on a cell
type specific promoter35, while the tail module interacts with transcription factors which
are bound to peripheral gene regulatory elements35. Also, the tail module, together with the
kinase module works to regulate the head and middle subunits. Deleting the kinase domain
of the Mediator complex leads to stressed genes. CDK8 can phosphorylate MED3 (tail
domain) and this leads to a decrease in transcriptional activation and subsequent decrease
in MED3 subunit expression36. Also, CDK8 can phosphorylate transcriptional activators
that are bound to the enhancer. MED13 acts as the connector between the kinase domain
and the rest of Mediator and is the target for most tumor suppressors and auxin-regulated
co-repressors that act through the upstream regulatory region36.
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Figure 1-4: Mediator is a 30- subunit complex, comprised of four modules that
bridges long-range interactions between enhancer-bound, cell-type specific
transcription factors and transcriptional machinery at gene promoters. (Figure
adapted from Straub J, Venigalla S, Newman JJ. Mediator’s Kinase Module: A
Modular Regulator of Cell Fate. Stem Cells Dev. 2020;29(24):1535-1551.
doi:10.1089/scd.2020.0164).
During cell culture studies, research has shown that the Mediator complex can be
isolated from cell extracts with or without the kinase module and studies have shown that
the kinase module can block interactions between Mediator and RNA polymerase II
enzyme36. In vitro transcription studies carried out on the Mediator complex show that the
absence of the kinase module renders the complex transcriptionally active while the
presence of the kinase domain renders the complex transcriptionally inactive. However,
little information exists to describe how these forms of Mediator are involved in
transcription in vivo. The Mediator complex plays an active role in transcription initiation
at core promoters that is different from its role at the enhancer region. This distinct property

11
of the Mediator complex at the enhancer and promoter region raises the possibilities that
there may be a change in a single Mediator complex during transcriptional activation 39–41.
The kinase module of the Mediator complex, which is made up of MED12, MED13, CDK8
and CCNC is associated with the rest of the Mediator through MED13 and has been shown
to be the only portion of the complex that demonstrates enzymatic activities. Knockdown
studies on any of the subunits have been shown to exhibit cell-type specific effects on
transcription and in regulation of cell fate and lineage commitment and this suggests a
unique role of the module and this makes it very vital to study.

1.6

MED12

MED12 has been shown to play a major role in stem cell regulation through
interactions with CDK8 and Cyclin C enzymatic activity. In human cells, the kinase
domain has been shown to be involved in the phosphorylation of certain transcription
factors such as the SREBP family and it is involved in lipid and carbohydrate metabolism
in yeast42. MED12 interactions have been implicated in ESC differentiation and
embryogenesis, as well as adult stem cell maintenance and potency43,44. MED12 acts as a
molecular switch that shuts down activated transcription upon binding to Mediator by
blocking re-initiation by RNAP II45. To date, specific roles of Mediator and MED12 in cell
state regulation are unclear, nevertheless, they are critical for understanding stem cell
regulation and enhancement of their clinical applications45.
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1.7

MED13

MED13 plays a vital role in the kinase module and connects the kinase domain to
the rest of the Mediator complex and has been known to play a role in developmental
processes in the cell. For example, MED13 regulates developmental gene expression
profiles in Drosophilia, Dano rerio (Zebrafish) and C. elegans46,47. Previous studies have
shown in mice that when MED13 is overexpressed, it forms a direct connection to CDK8
and the general Mediator complex. Also, MED13 plays an essential role in energy
homeostasis of the heart by regulating the expression of thyroid genes which play a role in
regulating energy homeostasis48.
1.8

CDK8 and CCNC

Cyclin-dependent kinases (CDKs) are a group of serine/threonine protein kinases
that are required for early embryogenesis and they serve as key regulators of both cell cycle
and transcription. CDK8 kinase activity has been linked to its ability to bind both CCNC
and MED12 by regulating the transcription factors involved in phosphorylation and
impacting the key transcriptional outputs that affect cellular and developmental
homeostasis49–51. Cyclin-dependent kinases (CDKs) are a group of serine/threonine protein
kinases that are required for early embryogenesis and they serve as key regulators of both
cell cycle and transcription. CDK8 kinase activity has been linked to its ability to bind both
CCNC and MED12 by regulating the transcription factors involved in phosphorylation and
impacting the key transcriptional outputs that affect cellular and developmental
homeostasis49–51.
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1.9

Research needs and Motivation

Previous studies have linked the kinase domain, specifically MED12 and MED13
to the regulation of gene expression during development. Both MED12 and MED13 play
a vital role in eye and wing development in Drosophilia where the absence or loss of
MED12 resulted in physiological differences of wing structure. In zebrafish, MED12 has
been linked as a co-factor in neural crest and endoderm development 55. Previous studies
have also identified MED12 as being essential for CDK8 and CCNC enzymatic activity.
MED12 interacts with CDK8 through a physical association with Cyclin C (CCNC), thus
making it vital to the function of the kinase domain43. Although the mechanism via which
MED12 performs this function is unknown, MED12 dependent CDK activation is essential
for nuclear transduction of the signals which are propagated by the different signaling
pathways in which MED12 is genetically and biochemically linked56. The loss of MED12
may lead to mutations and dysfunction that may result in mis-regulation of gene
expression. MED12 has been extensively studied in embryonic stem cells and
hematopoietic stem cells but to date, there is no study on the role of MED12 in human
adipose stem cells and its potential in driving adipogenesis and cell fate.
There is great clinical interest and therapeutic potential that comes from
understanding human adult stem cells. Adult stem cells have the potential to regenerate
whole organs from a few cells and have the potential to be used in a variety of tissue
engineering and regenerative medicine applications. Human adipose stem cells (hASCs),
the adult stem cells used in the studies described here, are multipotent and can differentiate
into cell types of multiple lineages.
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In the human body, negative modifications or mutations within the Mediator
complex may give rise to developmental diseases such as Lujan syndrome, Schizophrenia
and Optiz-Kaveggia syndrome. Mediator’s mechanism of action lies in the fact that it
functions to bridge the interactions between the cell-type specific transcription factors at
the enhancer region to the promoter region. A mutation in this role of the complex will lead
to a physical change in genomic architecture and communication within the cells may be
brought to a halt, resulting in disruption to cell fate43. The role of MED12 in normal cell
state and differentiation remain unclear, however, we are interested in studying
adipogenesis and transcriptional control of adipogenesis in a human model to provide
critical insights into causes of dysregulation and aberrant gene expression.
Understanding the molecular mechanism through which stem cell state is regulated
and adipogenesis is controlled will allow for the enhanced clinical application of these cells
in the future. Through the investigation of the kinase module of the Mediator complex we
can gain greater insight into how cell-type specific gene expression profiles are regulated,
the role of MED12 as a co-factor in interacting with adipogenic-specific transcription
factors, and how MED12 coordinates its action with other members of the kinase module.

CHAPTER 2
2.1
2.1.1

The effects of MED12 knockdown on adipogenesis in hASCs

Introduction
MED12, a critical subunit found in the kinase module of the Mediator complex, has

been extensively studied in embryonic stem cells and hematopoietic stem cells. However,
to date, there is no study on the role of MED12 in human adipose stem cells and its potential
in driving adipogenesis and cell fate. There is great clinical interest and therapeutic
potential that comes from understanding human adult stem cells. Adult stem cells, of which
adipose stem cells are a class, have the potential to regenerate whole organs from a few
cells and have the potential to be used in a variety of tissue engineering and regenerative
medicine applications. In addition, adult stem cells have immunomodulatory properties and
can be used as a therapeutic option in the treatment of certain autoimmune and
inflammatory conditions. Mediator’s mechanism of action lies in the fact that it functions
to bridge the interactions between cell-type specific transcription factors located at the
enhancer region to the transcriptional machinery at the promoter. A mutation in a subunit
of the complex may lead to a physical change in gene expression and communication
within the cells may be brought to a halt, ultimately causing a disruption in cell fate.
The precise role of the Mediator complex and each of its subunits in development
and disease remains vague despite numerous studies attempting to determine how
individual subunits function during lineage commitment and development. The kinase
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domain, made up of CDK8, CCNC, MED12, and MED13, is associated with the Mediator
complex through MED13 and it is the only portion of the complex that has been shown to
demonstrate enzymatic activities. Previous studies have shown that a mutation in any
subunit of the kinase module does not have an impact on gene expression but influences
cell-type specific transcription factors which suggests that the Mediator complex may be
responsible for directing cell fate and commitment. The kinase domain, just like the
Mediator complex, occupies enhancer elements and has been shown to phosphorylate
specific transcription factors such as PPARγ and C/EBPα that occupy these same genomic
regions.
We initially sought to determine the role of MED12 in adipogenesis. This was
achieved by assessing the phenotypic changes in the cells during adipocyte differentiation
following the siRNA-mediated knockdown of MED12. To address this objective, we used
hASCs and monitored the effects that the knockdown of MED12 has on gene expression
levels of the cells following induction of adipogenesis. Results of this study indicate a
regulatory role for MED12 in directing adipogenesis and lead towards an additional
understanding of how MED12 controls cell-type specific gene expression profiles. For the
next study, we ran Coimmunoprecipitation assays (CoIPs) to determine the interaction of
the subunits within the kinase module. The aim of this objective is to determine the role
of MED12 as it functions in the Mediator complex and its role in maintaining the structural
integrity of the kinase module. Given the importance of C/EBPα, and PPAR during
adipogenesis, we predicted that MED12 interacts with the transcription factors and kinase
module to direct gene expression.
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2.2
2.2.1

MATERIALS AND METHODS

hASCs Cell Culture
Culture Media: Human adipose-derived stem cells were purchased from Obatala

LLC and were received frozen in cryotubes at Passage 1 and stored in liquid nitrogen. The
cells were maintained in complete culture medium (CCM) containing 203.75ml MEM
Alpha (1X) (gibco;12561-049), 2.5ml of 1% L-glutamine (L-Glut) 200mM (100X) (gibco;
25030-081), 2.5ml of 1% penicillin streptomycin (gibco; 15140-122), and 41.25ml of
16.5% fetal bovine serum (FBS) (ATLANTA Biologicals; S11150). All components were
combined and filtered through a 0.22µm 250ml filter system (Corning; 430756). CCM
solution was stored at 4oC.
2.2.2

Cell Thawing
Cells were removed from the liquid nitrogen and thawed quickly using a water bath

at 37oC. The cells were transferred to a 15ml conical tube containing 4ml of warm CCM
and the tube was centrifuged at room temperature at 1500RPM for 10 minutes. At the end
of the centrifugation, the supernatant was aspirated using a sterile Pasteur pipette and the
cell pellet was resuspended in 10ml of CCM and incubated at 37°C at 5% CO2 . CCM media
was changed every 2 days until cells reached 70-80% confluency, at which point they were
passaged for continued expansion and for use in specific assays, as described below.

2.2.3

Cell Passaging
When cells reached appropriate confluency, they were rinsed using phosphate

buffered saline (PBS) (gibco; 10010-023). The cells were detached from the tissue culture
plates using 0.25% Trypsin-EDTA (1X) (gibco; 25200-056). Cells were then transferred
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to a conical tube containing CCM and centrifuged at room temperature at 1500RPM for 10
minutes. At the expiration of the centrifugation, the supernatant was aspirated, and cells
were resuspended in 1ml of CCM media. Cells were then counted by gently mixing 12µl
of the cell suspension and 12µl of Trypan Blue 0.4% (Lonza; 17-942E) in a 1.5ml
Eppendorf tube. Half of the solution was added to each side of a reusable hemocytometer
(Life Technologies, A25750) and counted with a Countess II FL automated cell counter
(Thermo Fisher AMQAX1000). Based on the live cell count, the desired number of cells
was plated for the different experiments to be carried out (Table 2-1). To calculate the
volume of cell suspension needed for the experiments, the desired cell number to be plated
was divided per milliliter of CCM used. For example, to plate 100,000 cells from a cell
pallet

suspended

in

1ml

of

media

with

a

live

cell

count

of

1.5*106,

(100,000/1.5*106)/1000µLs, 66.67µLs of cell suspension will be seeded.

Table 2-1: Cell seeding density for different tissue culture plate types
Plate type

Cell density

15cm
10cm

150,000 cells
100,000 cells

Volume
of
media
(mLs)
15
10

6cm
6-well

45,000 cells
20,000 cells/well

3
2

96-well

400 cells/well

0.2

Type of experiment

Passage, ChIP assay
Passage, Protein, differentiation, and
transfection
RNA, differentiation, and transfection
Differentiation, transfection, and some
staining techniques such as Oil-Red O
Cell viability
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2.2.4

Transfection
When cells reached 40% confluency, hASCs were transfected with 10µM stock

solutions of MED12 silencer select siRNA (Ambion; 4392420) or silencer select negative
control #1 siRNA (Ambion; 4390843), using lipofectamine RNAiMAX reagent
(Invitrogen; 56531) and Opti-MEM I (1X) (gibco; 31985-062) following the
manufacturer’s protocol. 24 hours after transfection media was replaced with adipogenic
differentiation media.
2.2.5

Adipogenic Differentiation
Adipogenesis was initiated in cells 24 hours after transfection by replacing CCM

with adipogenic differentiation media (AdipoQualTM Obatala, LaADM-500). Media was
changed every 72 hours until the different time points for the experiments were achieved.
2.2.6

Oil Red-O Staining
At the conclusion of each time point, a set of cells was fixed in formalin (Azer

Scientific, NBF-4-G) for 15 minutes at room temperature. The formalin was aspirated and
washed with PBS (gibco; 10010-023). The cells were stained with Oil Red-O
(Amresco,1320-06-5) and incubated at room temperature for 20 minutes and rinsed with
PBS three times. Phase-contrast imaging was used to detect lipid droplets with Oil Red-O
staining being used to further validate differentiation and visualize the cells.
To quantify cell differentiation, Oil Red-O was extracted from fixed samples, and
the absorbance was quantified with a plate reader. To extract the stain, 100% Isopropanol
(IBI 15735) was added to each well and allowed to incubate for 1 hour. 100µL of each
sample were transferred to a 96-well plate. Proteins were extracted from the remaining
cells using RIPA buffer (Abcam ab156034). The absorbance was read with a plate reader
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at optical density 540nm, and the protein was quantified using a Bradford assay. The
absorbance readout of the stain was normalized to the concentration of protein extracted
from the wells.
2.2.7

RNA Extraction
Cells were seeded on 6 cm plates for RNA extraction. RNA was collected from the

cells by rinsing with sterile PBS and extracted using TRIZOL reagent (Life Technologies
15596018) according to the manufacturer’s protocol for RNA extraction. RNA
concentrations were determined using the BioTek Cytation Take3 plate reader. 1µg of
RNA was used to generate cDNA using qScriptTM cDNA super mix (Quanta Biosciences,
95048-100) following the manufacturer’s protocol.
2.2.8

Quantitative Reverse Transcriptase PCR
Complimentary DNA (cDNA) was prepared with the use of the Quanta Q-script

mix manufacturer’s protocol (Quanta Biosciences, 95048-100), along with nuclease free
water (Quality Biological 351029721). qRT-PCR was performed using PowerUPTM SYBR
Green PCR master mix (Life technologies 1708033) and was run using the manufacturer’s
protocol on the Applied Biosystems StepOne PlusTM with annealing temperatures of 50oC
and extension at 60oC for 35 cycles. Gene expression levels were normalized to GAPDH
using CT values. Relative remaining transcript and fold change were calculated using the
2-ΔΔCT method. The results were reported as an average of three biological replicates and
the error bars was representative of the standard error of the mean. All primers used for the
PCR analysis are listed in table 2-2 below.
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Table 2-2: Primers used for reverse transcriptase PCR
Gene

Forward sequence (5ʹ-3ʹ)

Product
size
(bp)
Gapdh CCCCACTTGATTTTGGAGGGA
AGGGCTGCTTTTAACTCTGGT
206
med12 CGAAAAGGGACAGCAGAAAC
CCCATCCTCCCCACCTAAGA
87
med13 TGTCCTGCTCCTTCACCTTTT
GGCATAAGATAACTTGAAATGGGCT 150
Ccnc
GCTGATTTGATCGAGGAGCG
ATCCATTGCAAATAGTGGGAGC
148
cdk8
GCCAAGAGGAAAGATGGGAAGG GCCGACATAGAGATCCCAGTT
77
pparγ GCTGTTATGGGTGAAACTCTG
ATAAGGTGGAGATGCAGGTTC
351
c/ebpα TATAGGCTGGGCTTCCCCTT
AGCTTTCTGGTGTGACTCGG
94

2.2.9

Reverse sequence (5ʹ-3ʹ)

Protein Extraction and Quantification
hASCs were seeded in 10cm tissue culture plates for protein assays. Upon reaching

terminal time points, the cells were washed with PBS twice and collected using RIPA
buffer (Abcam ab156034) containing phosphatase and protease inhibitors (Thermo 88666).
The cells were lysed for 30 minutes at 4oC. The cell lysates were transferred into labelled
tubes and centrifuged at 4oC (12,000RPM for 20minutes) to isolate the proteins and
eliminate any cellular debris. Protein samples were quantified using BSA standard curves
generated from Bradford assays (Bio-Rad 5000006).
2.2.10

Coimmunoprecipitation assay (CoIP)
CoIP was performed using the Pierce Crosslink Magnetic IP/Co-IP kit following

manufacturer’s protocol (Thermo 88805). Binding of antibodies to the proteins A/G
magnetic beads was done by diluting the coupling buffer and lysis /wash buffer with
ultrapure water. The tubes were placed on a magnetic stand to collect the beads for 1
minute. After this step, the antibodies were diluted (1:10) with 20X coupling buffer and
1:20 with IP lysis/wash buffer to get a final antibody concentration of 2-10µg per 100µl
(Thermo Scientific). 100µl of prepared antibody solution was added to the beads, gently
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mixed, and incubated on a rotator for 15mins vertexing gently every 5mins to ensure the
beads remain in suspension. The beads were collected with a magnetic stand and the
supernatant was discarded.
Crosslinking of the bound antibody was done by diluting DSS 1:100 in DMSO
(VWR; N182-5X10ML) to make 0.25mM DSS. 2.5µl of 20X coupling buffer, 4ul of
0.25mM DSS and 43.5ul of ultrapure water to the beads to make up a total volume of 50ul.
The DSS is added at 10X molar excess to the Pierce Protein Magnetic beads at 20uM
working solution. The solution was incubated for 30miuntes and the beads were collected
with a magnetic stand. The flow through was saved to verify antibody crosslinking. Elution
buffer was added to the mix, vortexed, the supernatant removed, and this process was
repeated three times and the antibody-crosslinked beads were stored at 4°C or proceeded
to antigen precipitation.
The cells were washed with PBS and ice-cold IP lysis/wash buffer (Table 2-3) to
the cells and incubated on ice for 5minutes with periodic mixing. The lysate was microcentrifuged at ~13,000XG for 10minutes to pellet the cell debris and the supernatant was
transferred to a new tube for protein concentration determination. 500ul of protein lysate
or 200µg of protein sample was added to the tube containing crosslinked magnetic beads
and incubated overnight at 4°C on a rotator. Then the beads were collected with a magnetic
stand, the unbound sample was collected for western blot analysis. The collected beads
were washed two times with IP lysis/wash buffer and one time with ultrapure water. Beads
were collected on a magnetic stand and supernatants were discarded. 50µl of elution buffer
was added to the collected beads and incubated for 5 min at room temperature on a rotator.
Beads were collected magnetically and saved at -20°C for western blot analysis. 10µl of
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neutralization buffer was added to each 100µl of eluate to neutralize the low pH of the
sample collected. This elution step is repeated one more time for optimal antigen recovery.

Table 2-3: Volume of IP Lysis/Wash Buffer to use for different standard culture plates

2.2.11

Plate Size

Volume of IP Lysis/ Wash Buffer

10cm

500-1000µl

6cm

250-500µl

6-well

200-400µl/well

24-well

100-200µl/well

Western blot
SDS-PAGE was performed using a Mini PROTEAN TGXTM. Samples were loaded

in a polyacrylamide gel (Bio-Rad 4561084) at equal concentration, following the
manufacturer’s protocol. Proteins were transferred using transblot TurboTM PVDF transfer
pack (Thermo scientific 88518). After transfer, the membranes were cut into equal sizes
and blocked in 5% milk for 2 hours in 1X TBS with 0.1% Tween. The membrane was
probed overnight with primary antibody (1:1000), washed 5 times and probed with
secondary antibody (1:1000). The blots were developed and visualized with ECL and
chemiluminescence (Bio-Rad 1705060). Below is a table showing the list of antibodies
used in this study (Table 2-4).
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Table 2-4: Antibodies used in Western blot assay
Protein
MED12
MED13
CDK8
CCNC
PPARγ
Gapdh
Goat Anti-Rabbit
IgG H&L (HRP)
C/EBPα

Protein
size
250kDa
268kDa
58kDa

Host specie

Company

Rabbit
Rabbit
Rabbit

Bethyl
Bethyl
Bethyl

28kDa
57.6kDa
37kDa

Rabbit
Rabbit
Rabbit
Rabbit
(Target)
Rabbit

37kDa

2.3

Catalog no

Dilution

A300-774A
A301-278A
A302-501AM
Bethyl
A301-989A
Thermo Fisher PA3-821A
Abcam
Ab9485
Abcam
Ab6721

1:1000
1:1000
1:1000

Thermo Fisher PA1-337

1:1000

1:1000
1:500
1:1000
1:500

Statistical Analysis

Statistical analysis was performed using the students 2-tailed T tests where
necessary.
2.4
2.4.1

Results

MED12 siRNA effectively decreased MED12 transcript and protein

expression
To study MED12 in adipogenesis we first needed to ensure that the knockdown
persisted over a differentiation time course of 14 days. To do this, the levels of MED12
were diminished via siRNA-mediated transfections and validation of the efficacy of the
knockdown was determined by qRT-PCR assays (Figure 2-1A), and Western blots (Figure
2-1B). It was observed that there was a significant loss of MED12 transcript i.e., ~70%
reduction (P-value <0.05) in the amount of MED12 transcript observed at 3-, 7- and 14days post transfection (Figure 2-1A) and approximately a 70% drop in MED12 protein as
quantified via ImageJ analysis (Figure 2-1C).
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Figure 2-1: Validation of MED12 knockdown. A. siRNA-mediated
knockdown of MED12 was analyzed by qRT-PCR. Results indicate a
significant decrease (p<0.05) of MED12 gene normalized to GAPDH.
Studies were performed in biological triplicates and error bars denote SE of
the mean and (**) indicates P<0.05 for all genes. B. Western blot was
performed to validate successful reduction in MED12 protein after
knockdown. C. ImageJ analysis was used to quantify amount of protein
remaining after knockdown. Western blot analysis represents biological
triplicates of whole cell lysates, normalized to GAPDH.
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2.4.2

Characterization of Adipose Stem Cells
Once we had established reliable and robust knockdown of MED12 during

adipogenesis, we wanted to determine the influence of the knockdown on adipogenesis We
first observed differentiation through phase contrast imaging (Figure 2-2A) and then
studied the morphological changes and formation of lipid vesicles through Oil Red-O
staining and staining extraction technique (Figure 2-2B & Figure 2-2C). In this experiment,
adipocyte differentiation was induced, and cells were fixed and imaged at 3-, 7- and 14days following siRNA mediated knockdown of MED12. A single transfection was
performed 24 hours prior to initiating differentiation. Imaging was done using a Biotek
citation imager and adipogenic differentiation was indicated via Oil Red O stain, in which
the lipid droplets were stained red and indicated with arrows. Results of this study show an
increase in the number of lipid droplets over time in the negative control cells with a
striking decrease in adipocyte differentiation and lipid droplet accumulation following the
knockdown of MED12. From this study, we can conclude that MED12 may play a role in
the regulation of adipogenesis under standard culture conditions.
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Figure 2-2: Characterization of adipose stem cells. A. Phase contrast of
adipogenic differentiated hASCs at 3,7- and 14-days post transfection. B. Color
micrograph of adipogenic differentiated hASCs at 3,7- and 14-days post
transfection. Staining of lipid droplets was done using Oil Red O and lipid
droplets are indicated with arrows. C. Oil Red O extraction. All data points are
the average of three biological replicates and error bars indicate standard error of
the mean and (**) indicates P<0.05 for all genes.
.

29
2.4.3

MED12 knockdown plays a role in the expression of adipogenic transcription

factors
To further confirm and investigate the influence of MED12 on adipogenesis, we
examined adipogenic markers PPARγ and C/EBPα, both well characterized transcription
factors responsible for inducing early adipogenesis. We performed qRT-PCR to examine
expression levels PPARγ, (Figure 2-3A) and C/EBPα (Figure 2-3B) and observed a
decrease in expression following the knockdown of MED12. This supports the hypothesis
that MED12 does have a role in directing adipogenic-specific gene expression and may be
involved in activating the genes that are responsible for adipocyte differentiation of adipose
stem cells.
Since a decrease in transcript levels does not always translate to a decrease in
protein expression, we further confirmed the influence of the MED12 knockdown on
adipogenic transcription factors by examining the protein levels of PPARγ, a master
regulator of adipogenesis. This study was carried out by running a western blot assay of
PPARγ at day 3, 7 and 14 (Figure 2-3C), following the induction of adipogenesis. We
found that the knockdown of MED12 significantly reduced the protein expression of
PPARγ at all time points after induction of adipogenesis in hASCs via ImageJ analysis
(Figure 2-3D). This result suggests that MED12 acts to inhibit differentiation, suggesting
that under normal conditions in the cell, MED12 promotes adipogenesis.
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Figure 2.3: MED12 knockdown plays a role in the expression of adipogenic
transcription factors. A. qRT-PCR confirmed decrease in adipogenesis after
3 and 7 days and an increase after 14days of induction with significant
increases in transcript for PPARγ. P values 0.048772, 0.051821, 0.077405 for
days 3, 7 and 14 days, respectively.
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B. qRT-PCR confirmed decrease in CEBPα. p values 0.008403,0.011366
and 0.000141 for days 3, 7 and 14 days, respectively. CEBPα and PPARγ
genes are normalized to gapdh and studies were performed in triplicates.
Error bars are the average of three biological replicates and represent
standard error of the mean and (**) indicates P<0.05 for all genes.
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C. Protein analysis confirms a decrease in PPARγ expressions following
induction of adipogenesis at day 3, 7 and 14 days. D. ImageJ analysis was
used to quantify precent protein remaining after knockdown. Western blot
analysis represents biological triplicates of whole cell lysates, normalized to
GAPDH.
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2.4.4

MED12 influences other subunits of the kinase module during adipogenesis
Previous studies have linked the kinase domain, specifically MED12 and MED13,

to the regulation of gene expression during development. It has also been observed that
MED12 is essential for CDK8 and CCNC enzymatic activity. MED12 interacts with CDK8
through a physical association with Cyclin C (CCNC), thus making it vital to the function
of the kinase domain57. Given these relationships, we were interested in knowing how the
knockdown of MED12 influenced the expression of other subunits of the kinase module
such as MED13 (Figure 2-4A), CDK8 (Figure 2-4B) and CCNC (Figure 2-4C). qRT-PCR
was used to determine the transcript levels of the kinase module subunits while western
blots were used to determine the protein expression of each subunit following the
knockdown of MED12 and results were analyzed via ImageJ analysis (Figure 24D&E).
We observed an increase in MED13 at day 7 and 14, CDK8 at day 14 and CCNC at day 7.
Western blots result indicates that CDK8 was not affected in any way by the knockdown
of MED12 and CCNC had low expressions in the absence of MED12. This fluctuation in
patterns of expression may be the result of compensation for a downstream transcriptional
block of the cells following the reduced expression of MED12. Although the mechanism
via which MED12 performs this function is unknown, MED12 dependent CDK activation
is essential for nuclear transduction of the signals which are propagated by the different
signaling pathways in which MED12 is genetically and biochemically linked.
After several attempts to run a western blot assay on MED13, we have not been
able to get the bands to show up despite trying different methods and different gels. We
hope to get some results, but at the time of writing this result, we are yet to get any results
for MED13.
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Figure 2.4: MED12 influences other subunits of the kinase module
during adipogenesis. A. qRT-PCR showing a significant decrease of
transcript levels of MED13 at day-3, a significant increase at 7 days
and little change at day 14.
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B. qRT-PCR showing a significant decrease in transcript levels of
CDK8 at day-3 and 7 and a return closer to controls by day 14.
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C. qRT-PCR showing a decrease in transcript levels of CCNC at day-3 and a
significant increase at day 7 and a further decrease at day 14. Results are
normalized to gapdh and were performed in biological triplicates. Error bars are
the average of three biological replicates and represent standard error of the
mean and (**) indicates P<0.05 for all genes.
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Figure 2-4: MED12 influences other subunits of the kinase module during
adipogenesis. D. Protein analysis confirms a decrease in expressions of CCNC and
no change in the expression of CDK8 following knockdown of MED12 and induction
of adipogenesis at day 3, 7 and 14 days. E. ImageJ analysis was used to quantify
precent protein remaining after knockdown. Western blot analysis represents
biological triplicates of whole cell lysates, normalized to GAPDH.
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2.4.5

Interaction of subunits within the kinase module
We wanted to know the role of MED12 in maintaining the structural integrity of

the complex by monitoring the physical interactions of protein complexes within the cells.
To accomplish this goal, we used Co-Immunoprecipitation assays and antibodies targeting
MED12 to pull down MED12 and identify which part of the kinase module are directly
interacting with this specific subunit. Each Co-IP experiment was subjected to SDS-PAGE
and membrane transfer before being probed for MED12 as well as other subunits of the
kinase module and adipogenic transcription factors like PPARγ and C/EBPα.
Results from this study indicate that CDK8, CCNC, C/EBPα and PPARγ were each
pulled down along with MED12 at all the timepoints as observed in the elute. However,
CDK8 was expressed in both elute and unbound cells which could indicate that there might
be more CDK proteins not interacting with MED12 or the amount of antibody used for the
target protein is saturated hence the appearance of unbound proteins. It is also noteworthy
to add that the results from Day 3 had a lot of background which hindered the bands from
being seen clearly A repeat of the study may be carried out, but at the time of writing this
report, it is yet to be done (Figure 2-5A, 2-5B, 2-5C, 2-5D).
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Figure 2-5: Coimmunoprecipitation assays of the proteins of the kinase subunits and
transcription factors at Day 0,3,7 and 14 following the loss of MED12. Co-IP for
MED12 was being done to confirm knockdown and possibly account for any
remaining protein that might have been observed.

CHAPTER 3
3.1
3.1.1

CONCLUSION

Understanding the mechanism of Regulation
This study sought to investigate the role of MED12 in relation to the Mediator

complex and kinase domain to better understand transcriptional control of adipogenesis in
hASCs. The goal was to not only determine changes in adipogenesis in the absence of
MED12, but to also identify and understand interactions between MED12 and transcription
factors that control adipogenesis. The results of this study have helped to disclose some
insights into how cell-type specific gene expression is regulated by MED12. The
knockdown of MED12 indicated a decrease in adipocyte differentiation and lipid droplet
formation as compared to the control which had an increased number of lipid droplets
(Figure 2-2). We then went further to investigate the relationship between MED12 and
adipogenic transcription factors such as PPARγ and C/EBPα, master regulators of
adipogenesis. We performed qRT-PCR and western blot assays which indicated reduced
transcript and protein of adipogenic transcription factors following the diminished
expression of MED12 (Figure 2-3). This indicates a regulatory role for MED12 in directing
adipogenesis and provides an additional layer of understanding for how MED12 controls
cell-type specific gene expression profiles.
Once we had established a role for MED12 in adipogenesis, we were interested in
knowing how the knockdown of MED12 influenced other subunits of the kinase domain.
Here, the knockdown of MED12 showed a decrease in MED13 transcript at day 3 and an
increase at days 7 and 14. The increase in transcript level may indicate MED13 trying to
compensate for the decrease in MED12 expression. Knockdown of MED12 led to a

41

42
decrease in CDK8 transcript at day 3 and day 7, a decrease in Cyclin C on day 3 and
subsequent increase of Cyclin C transcript at days 7 and 14 (Figure 2-4). These results may
indicate that MED12 is essential for activating the CDK/Cyclin C kinase activity and
subsequent transcriptional activation of target genes. In addition, for the protein levels of
the kinase module, CDK8 showed no significant decrease in the levels of protein at all
experimental time points and suggests that MED12 does not have any effect on the CDK8
kinase module, and so CDK8 may act independently of the Mediator complex as reported
by previous literature44. Finally, we aimed to determine the role of MED12 as it functions
in the Mediator complex and its role in maintaining the structural integrity of the kinase
module. Co-immunoprecipitation assays were performed to determine interactions
between MED12, CDK8, Cyclin C, C/EBPα and PPARγ (Figure 2-5). Results indicate that
CDK8 was present in the elute and bound to MED12 while CCNC is not bound to MED12.
These results suggests that an amount of CDK8 remains free of MED12 or that the amount
of CDK8 antibody used for co-IP is saturated and our assay requires further optimization.
CEBPα was found bound to MED12 suggesting a possible interaction between MED12
and CEBPα. Given the importance of C/EBPα, and PPARγ during adipogenesis, and based
on our result, we suggest that MED12 interacts with the transcription factors and kinase
module to direct gene expression.
Taken together, this study provides evidence for a regulatory role of MED12 in
directing adipogenesis of hASCs. These findings aid in our understanding of adipocyte
biology and the potential role for these cells in regenerative medicine and therapeutics for
clinical research. Adipogenesis has become one of the most extensively studied processes,
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and the focus on the availability of human adipose stem cell models to study
adipogenesis57.
Previous studies have linked the kinase domain, specifically MED12 and MED13
to the regulation of gene expression during development. Both MED12 and MED13 play
a vital role in eye and wing development in Drosophilia where the loss of MED12 was
shown to result in physiological differences of wing structure. In zebrafish, MED12 has
been linked as a co-factor in neural crest and endoderm development1. MED12 has been
identified as being critical for CDK8 and CCNC enzymatic activity and interacts with
CDK8 through a physical association with Cyclin C (CCNC), thus making it a vital part of
the function of the kinase domain44.
Here, we show a novel study that demonstrates that the knockdown of MED12 in
hASCs blocks differentiation and reduces adipogenesis indicating a cell specific role for
this protein in adipogenesis. In this study, we demonstrated that the knockdown of MED12
resulted in decreased adipogenesis and transcription of adipocyte transcription factors,
suggesting that MED12 is required for maintaining PPARγ and C/EBPα gene expression.
As PPARγ and C/EBPα are required for adipogenesis55, the data presented in this thesis
provides additional information to the field by identifying another factor critically involved
in the initiation of differentiation. Hence knowledge from the study can be used in
understanding and treating human disease such as obesity by stopping transcriptional misregulation and understanding regulatory mechanisms that can lead to several metabolic
conditions, including heart diseases, stroke, diabetes etc.
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3.1.2

Future work

The insight gained from the research presented here has led to several questions and
opportunities for future investigation. From our studies, many questions arise about how
exactly MED12 regulated adipogenesis. This can be answered using chromatin
immunoprecipitation (ChIP) assays which uncovers DNA-proteins interaction within the
cell. It may be vital to determine subunit interactions and genome occupancy within the
cells and studies on chromatin modifiers of the kinase subunit genes to better understand
binding patterns of MED12 and the Mediator complex with the general transcriptional
machinery. In addition, a further understanding of how other subunits of the kinase module
influence adipogenesis is of great interest. To achieve this goal, shRNA-containing
lentivirus will be used to knockdown specific subunits of the Mediator complex kinase
module. This type of knockdown technology allows for the integration of shRNA into the
genome and the establishment of cell lines, ultimately leading to greater consistency and
overall efficiency in studies. Finally, questions related to global gene expression changes
during adipogenesis following the knockdown of proteins like Med12 remain. Microarrays
and RNAseq will help to effectively establish what genes are affected by the knockdown
induced decreased expression of MED12 and aid in identifying novel targets of MED12
that may be used to control cell fate. Going forward with this study will aid in further
understanding the processes of adipogenesis and the relationship between the Mediator
complex, transcription factors and the genomic elements that determine cell fate.
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